ASSOCIATION OF INFECTIOUS FACTORS WITH BILIARY TRACT DISEASES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In order to study the relationship of biliary tract disease with markers of infection Helicobacter pylori (H. pylori) performed an ultrasound scan of the gallbladder, clinical examination and collection of serum for detection of antibodies to H. pylori in 586 patients aged 18 to 85 years; Esophagofibregastroduodenoscopy performed in 297 cases; target biopsy from antrum division of stomach mucosa with followed definition of H. pylori contamination by morphological method performed in 147 patients. Serological and morphological indicators of H. pylori contamination in patients with cholecystitis and cholelithiasis were higher than in healthy individuals.

Full Text

Restricted Access

About the authors

J. Tonkih

Scientific Research Institute for Medical Problems of the North, Siberian Division of Russian Academy of Medical Sciences

V. Tsukanov

Scientific Research Institute for Medical Problems of the North, Siberian Division of Russian Academy of Medical Sciences

References

  1. Аруин Л.И., Исаков В.А. Оценка обсемененности слизистой оболочки желудка Helicobacter pylori и активности хронического гастрита // Арх. пат. -1995; 3: 75-6.
  2. Цуканов В.В. Клинико-биохимические особенности заболеваний желчевыводящих путей у населения азиатского Севера. Автореф. дис.. докт. мед. наук. Томск, 1996; 40 с.
  3. Цуканов В.В., Амельчугова О.С., Буторин Н.Н. и др. Современные аспекты эрадикации Helicobacter pylori // Тер. арх. - 2013; 2: 73-6.
  4. Цуканов В.В., Ноздрачев К.Г., Тонких Ю.Л. и др. Метаболические факторы защиты коренного населения Севера при ИБС и холелитиазе // Бюл. СО РАМН. - 2006; 2: 100-4.
  5. Цуканов В.В., Ноздрачев К.Г., Тонких Ю.Л. и др. Механизм обратного транспорта холестерина и холелитиаз у северных народностей // Клин. мед. -2007; 85 (2): 33-5.
  6. Цуканов В.В., Тонких Ю.Л., Бронникова Е.П. и др. Механизм нормолипидемии у северных народностей // Клин. мед. - 1999; 2: 38-42.
  7. Штыгашева О.В., Цуканов В.В. Ассоциация Cаg A и Vac A штаммов Helicobacter Pylori и язвенной болезни в организованной популяции г. Абакана // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2004; 14 (2): 84-7.
  8. Ивашкин В.Т., Маев И.В., Лапина Т.Л. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 1: 87-9.
  9. Admirand W., Small D. The physicochemical basis of cholesterol gallstone formation in man // J. Clin. Invest. - 1968; 47 (5): 1043-52.
  10. Arismendi-Morillo G., Cardozo-Ramones V., Torres-Nava G. et al. Histopathological study of the presence of Helicobacter pylori-type bacteria in surgical specimens from patients with chronic cholecystitis // J. Gastroenterol. Hepatol. - 2011; 34 (7): 449-53.
  11. Carey M. Pathogenesis of gallstones // Am. J. Surg. - 1993; 65 (4): 410-9.
  12. Chen D., Hu L., Yi P., Liu W. et al. H. pylori are associated with chronic cholecystitis // World J. Gastroenterol. - 2007; 13 (7): 1119-22.
  13. Fujioka T., Aoyama N., Sakai K. et al. A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan // J. Gastroenterol. - 2012; 47 (3): 276-83.
  14. Gisbert J., Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough // Aliment. Pharmacol. Ther. - 2011; 34 (11): 1255-68.
  15. Hamada T., Yokota K., Ayada K. et al. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease // Helicobacter. - 2009; 14 (6): 545-51.
  16. Lemos R., Franзa P., Ferreira L. et al. Detection of bacterial DNA in acute and chronic cholecystitis // Br. J. Surg. - 2010; 97 (4): 532-6.
  17. Malfertheiner P., Megraud F., O’Morain C. et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report // Gut. - 2012; 61 (7): 646-64.
  18. Shih S., Yang H., Chang T. et al. Investigation of cytotoxic T-lymphocyte-associated protein 4 gene polymorphisms in symptomatic gallstone disease // Hum. Immunol. - 2011; 72 (4): 355-8.
  19. Tepes B., O’Connor A., Gisbert J. et al. Treatment of Helicobacter pylori infection 2012 // Helicobacter. - 2012; 17 (1): 36-42.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies